INTRODUCTION: Appendicitis is the most common emergency condition in children. Historically, a 3-drug regimen consisting of ampicillin, gentamicin, and clindamycin (AGC) has been used postoperatively for perforated appendicitis. A retrospective review at our institution has found single day dosing of ceftriaxone and metronidazole (CM) to be a more simple and cost-effective antibiotic strategy. Therefore, we performed a prospective, randomized trial to compare efficacy and cost-effectiveness of these 2 regimens. METHODS: After internal review board approval (IRB no. 04 12-149), children found to have perforated appendicitis at appendectomy were randomized to either once daily dosing of CM (2 total doses per day) or standard dosing of AGC (11 total doses per day). Perforation was defined as an identifiable hole in the appendix. The operative approach (laparoscopic), length of antibiotic use, and criteria for discharge were standardized for the groups. Based on our retrospective analysis using length of postoperative hospitalization as a primary end point, a sample size of 100 patients was calculated for an alpha of .5 and a power of 0.82. RESULTS:One hundred patients underwentlaparoscopic appendectomy for perforated appendicitis. On presentation, there were no differences in sex distribution, days of symptoms, temperature, or leukocyte count. There was no difference in abscess rate or wound infections between groups. The CM group resulted in significantly less antibiotic charges then the AGC group. CONCLUSIONS: Once daily dosing with the 2-drug regimen (CM) offers a more efficient, cost-effective antibiotic management in children with perforated appendicitis without compromising infection control when compared to a traditional 3-drug regimen.
RCT Entities:
INTRODUCTION:Appendicitis is the most common emergency condition in children. Historically, a 3-drug regimen consisting of ampicillin, gentamicin, and clindamycin (AGC) has been used postoperatively for perforated appendicitis. A retrospective review at our institution has found single day dosing of ceftriaxone and metronidazole (CM) to be a more simple and cost-effective antibiotic strategy. Therefore, we performed a prospective, randomized trial to compare efficacy and cost-effectiveness of these 2 regimens. METHODS: After internal review board approval (IRB no. 04 12-149), children found to have perforated appendicitis at appendectomy were randomized to either once daily dosing of CM (2 total doses per day) or standard dosing of AGC (11 total doses per day). Perforation was defined as an identifiable hole in the appendix. The operative approach (laparoscopic), length of antibiotic use, and criteria for discharge were standardized for the groups. Based on our retrospective analysis using length of postoperative hospitalization as a primary end point, a sample size of 100 patients was calculated for an alpha of .5 and a power of 0.82. RESULTS: One hundred patients underwent laparoscopic appendectomy for perforated appendicitis. On presentation, there were no differences in sex distribution, days of symptoms, temperature, or leukocyte count. There was no difference in abscess rate or wound infections between groups. The CM group resulted in significantly less antibiotic charges then the AGC group. CONCLUSIONS: Once daily dosing with the 2-drug regimen (CM) offers a more efficient, cost-effective antibiotic management in children with perforated appendicitis without compromising infection control when compared to a traditional 3-drug regimen.
Authors: A Schmidt-Matthiesen; H Röding; J Windolf; D Sommerfeldt; C Gutt; A Pannike; A Encke Journal: Chemotherapy Date: 1999 Sep-Oct Impact factor: 2.544
Authors: G J de Klerk; J H van Steijn; S Lobatto; C A Jaspers; W C van Veldhuizen; C A Hensing; M C Bunnik; W H Geraedts; A S Dofferhof; J Van Den Berg; J H Melis; A I Hoepelman Journal: Int J Antimicrob Agents Date: 1999-07 Impact factor: 5.283
Authors: Shawn D St Peter; Danny C Little; Casey M Calkins; J Patrick Murphy; Walter S Andrews; George W Holcomb; Ronald J Sharp; Charles L Snyder; Daniel J Ostlie Journal: J Pediatr Surg Date: 2006-05 Impact factor: 2.545
Authors: E Marty Knott; Priscilla Thomas; Nicole E Sharp; Alessandra C Gasior; Shawn D St Peter Journal: Pediatr Surg Int Date: 2013-07-27 Impact factor: 1.827
Authors: Michael R Arnold; Blair A Wormer; Angela M Kao; David A Klima; Paul D Colavita; Graham H Cosper; Brant Todd Heniford; Andrew M Schulman Journal: Pediatr Surg Int Date: 2018-09-14 Impact factor: 1.827
Authors: Joseph A Sujka; Katrina L Weaver; Justin A Sobrino; Ashwini Poola; Katherine W Gonzalez; Shawn D St Peter Journal: Pediatr Surg Int Date: 2018-12-03 Impact factor: 1.827
Authors: Tyler J Loftus; Scott C Brakenridge; Chasen A Croft; R Stephen Smith; Philip A Efron; Frederick A Moore; Alicia M Mohr; Janeen R Jordan Journal: J Surg Res Date: 2017-11-13 Impact factor: 2.192
Authors: Hanna Alemayehu; Amita A Desai; Priscilla Thomas; Susan W Sharp; Shawn D St Peter Journal: Pediatr Surg Int Date: 2014-01-28 Impact factor: 1.827
Authors: Kin Wai Edwin Chan; Kim Hung Lee; Jennifer Wai Cheung Mou; Sing Tak Cheung; Jennifer Dart Yin Sihoe; Yuk Him Tam Journal: Pediatr Surg Int Date: 2010-02 Impact factor: 1.827